Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by:
University Hospital, Bonn
ClinicalTrials.gov Identifier:
NCT00510965
First received: August 1, 2007
Last updated: June 14, 2012
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
No publications provided by University Hospital, Bonn

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):